Pharmaceutical Technology

DECEMBER 4, 2023

GlobalData tracks 11 drugs in development for Grass Pollen Allergy by ten companies/universities/institutes. The top development phase for Grass Pollen Allergy is phase ii, with six drugs in that stage.

Allergies 130

Allergies Development Drugs 130

pharmaphorum

FEBRUARY 19, 2024

Fast approaching the end of its patent life, Roche and Novartis’ Xolair is going out with a bang, picking up a new approval as the first and only drug therapy for people with food allergies in the US.

Allergies 125

Allergies Medicine Drugs 125

Fierce Pharma

FEBRUARY 16, 2024

People with food allergies finally have a drug that can help prevent severe outcomes—and it’s a drug that’s been on the market for two decades. People with food allergies finally have a drug that can help prevent severe outcomes—and it’s a drug that’s been on the market for two decades.

Allergies 129

Allergies FDA Approval Marketing Medicine 129

Fierce Pharma

DECEMBER 19, 2023

On the market for two decades for asthma, Novartis and Roche’s Xolair is closing in on a new indication as a way for those with food allergies to avoid severe outcomes. | On the market for two decades for asthma, Novartis and Roche’s Xolair is closing in on a new indication as a way for those with food allergies to avoid severe outcomes.

Allergies 121

Allergies Marketing 121

Pharmaceutical Technology

DECEMBER 22, 2023

Regeneron Pharmaceuticals Inc granted patent for preventing or treating allergies. Learn about the method involving IL-4R antagonists and specific dosage instructions.

Allergies 100

Allergies 100

Drug Patent Watch

FEBRUARY 12, 2024

Annual Drug Patent Expirations for FLONASE+SENSIMIST+ALLERGY+RELIEF Flonase Sensimist Allergy Relief is a drug marketed by Glaxosmithkline Cons and is included in one NDA. There… The post New patent for Glaxosmithkline Cons drug FLONASE SENSIMIST ALLERGY RELIEF appeared first on DrugPatentWatch - Make Better Decisions.

Allergies 59

Allergies Drugs Marketing 59

XTalks

OCTOBER 6, 2022

According to the Asthma and Allergy Foundation of America, about 32 million people in the US have food allergies, which means allergy friendly food brands not only have a large audience base, but are also necessities. Partake Foods has become one of the most popular allergy friendly food brands and it recently secured $11.5

Allergies 90

Allergies Branding Production Packaging 90

pharmaphorum

OCTOBER 10, 2022

For the 32 million individuals in the US with food allergies, more research into symptoms, causes, and treatments has been long sought after, but historically underfunded. per person being spent on food allergy research. Luckily for those with food allergies, the food allergy sector has benefitted from this influx of funding.

Allergies 109

Allergies Marketing Doctors Doctor 109

Medical Xpress

MAY 9, 2023

Having a latex allergy is no fun, but it can be a real challenge for health professionals who have to work with a wide variety of medical equipment that can contain the allergen.

Allergies 105

Allergies Containment 105

Medical Xpress

APRIL 4, 2023

Children with food allergies might experience heightened anxiety over social situations involving food. A Baylor College of Medicine psychologist explains how parents can alleviate this stress while teaching them to be mindful of their allergies.

Allergies 90

Allergies Medicine 90

Bio Pharma Dive

SEPTEMBER 5, 2023

The FDA-approved therapy, called Palforzia, was little used, leading Nestle to abandon a business it had secured in a $2.6 billion deal three years ago.

Allergies 321

Allergies Sales FDA Approval 321

Trialfacts

JANUARY 23, 2024

More Study Details About the Study A peanut allergy can be severe and life-threatening if not treated promptly. Peanut allergies are one of the most common food allergies in children in the USA, with more than 2% of children being affected. Participants will receive a new potential treatment for their peanut allergy at no cost.

Allergies 52

Allergies Research Doctors Doctor 52

Medical Xpress

APRIL 6, 2023

Black and Hispanic patients with severe allergies are less likely to get a common treatment, allergen immunotherapy, compared to white patients, according to Penn State College of Medicine researchers.

Allergies 77

Allergies Medicine Development Research 77

NPR Health - Shots

APRIL 2, 2023

Patients who have digestive symptoms only after eating red meat may have developed an allergy caused by ticks. Previously, doctors looked for symptoms such as rashes, hives and breathing troubles. Image credit: Getty Images)

Allergies 134

Allergies Doctors Doctor Development 134

NY Times

DECEMBER 11, 2020

British health officials recommended that people with severe allergy reactions not be given the vaccine. Such reactions to vaccines are rare, even in people who have allergies to food or bee stings.

Allergies 140

Allergies Vaccination Vaccine Clinical Trials 140

Medical Xpress

MAY 3, 2023

A new Nature Immunology study led by University of Pittsburgh and National Institutes of Health researchers sheds light on how a rare type of helper T cell, called Th9, can drive allergic disease, suggesting new precision medicine approaches to treating allergies in patients with high levels of Th9.

Allergies 124

Allergies Medicine Research 124

Fierce Pharma

SEPTEMBER 5, 2023

billion acquisition, Nestlé has finally found a new owner for its peanut allergy drug Palforzia. billion acquisition, Nestlé has finally found a new owner for its peanut allergy drug Palforzia. After lackluster sales dampened the initial enthusiasm that came with a $2.1

Allergies 76

Allergies Drugs Sales 76

Medical Xpress

NOVEMBER 28, 2022

Philip Li from the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) has pioneered a new nurse-led penicillin allergy triage and testing strategy—the Hong Kong Drug Allergy Delabelling Initiative (HK-DADI), and demonstrated its effectiveness and safety compared to traditional allergy testing.

Allergies 98

Allergies Nurses Medicine Drugs 98

Pharmaceutical Commerce

FEBRUARY 16, 2024

Xolair (omalizumab) was previously granted FDA Priority Review status and Breakthrough Therapy Designation to prevent severe allergic reactions after accidental exposure to one or more foods in people with allergies.

Allergies 52

Allergies FDA Approval 52

XTalks

JANUARY 17, 2023

The US Food and Drug Administration (FDA) has added sesame to its list of major allergens, making it easier for people with sesame allergies to safely consume packaged food without fear of an allergic reaction. Related: Top 3 Allergy Friendly Food Brands. percent of children and adults in the US are allergic to sesame.

Allergies 98

Allergies Packaging Packaging Containment 98

Drug Discovery World

JUNE 26, 2023

IgGenix has made advances towards a peanut allergy therapeutic based on IgG4 monoclonal antibodies. The company’s research data was presented during the 2023 European Academy of Allergy and Clinical Immunology (EAACI) Congress, in Hamburg, Germany. The post Could a monoclonal antibody treat peanut allergy?

Allergies 52

Allergies Antibody In-Vivo In-Vitro 52

Pharma Times

FEBRUARY 10, 2022

Research demonstrates that people who live with peanut allergies face isolation and discrimination

Allergies 114

Allergies Research 114

Scienmag

DECEMBER 22, 2021

There have been many research efforts describing the nature and progression of dog allergies, but there have been very few applied studies that use this information to try to cure people of dog allergies entirely by artificially inducing immune tolerance.

Allergies 94

Allergies Research Vaccination Vaccine 94

Delveinsight

AUGUST 2, 2021

Peanut allergy (PA) is one of the most common food allergies that affect children in Western nations. Historically, the gold standard of the treatment for Peanut allergy constituted a strategic plan for peanut avoidance coupled with an adrenaline auto-injector (AAI) in case of contingencies.

Allergies 97

Allergies Marketing Development Trials 97

Medical Xpress

DECEMBER 2, 2022

The presence of food-specific IgA antibodies in the gut does not prevent peanut or egg allergies from developing in children, according to a Northwestern Medicine study published in Science Translational Medicine.

Allergies 81

Allergies Antibody Medicine Development 81

Pharmaceutical Technology

DECEMBER 20, 2023

The FDA accepted the filing based on NIH-funded Phase III trial interim results, with an approval decision expected in Q1 2024

Allergies 244

Allergies Trials 244

Medical Xpress

MARCH 17, 2023

Peanut allergy could plummet by 77 percent if peanut products were added to all babies' diets at four to six months of age, according to new research led by the University of Southampton, Kings College London, and the National Institute for Health and Care Research (NIHR).

Allergies 97

Allergies Production Research 97

Medical Xpress

JANUARY 2, 2023

Keeping allergies and asthma in check in the new year is a resolution worth keeping.

Allergies 97

Allergies 97

Medical Xpress

MARCH 16, 2023

I have had allergies since childhood, suffering during both the spring and fall seasons. I'm beginning to wonder if my symptoms are really from allergies or if they may be caused by a sinus infection instead. This past month, however, I am experiencing more congestion and mucus, and I even have some facial pain.

Allergies 68

Allergies 68

Medical Xpress

DECEMBER 16, 2022

Taking action to be evaluated for a penicillin allergy can impact your health, safety and wallet. population reports a penicillin allergy, but less than 1% is allergic after testing. According to the Centers for Disease Control and Prevention, 10% of the U.S. Common penicillins include ampicillin, amoxicillin and Augmentin.

Allergies 72

Allergies 72

pharmaphorum

SEPTEMBER 4, 2023

Nestle sells underperforming peanut allergy drug Phil.Taylor Mon, 04/09/2023 - 10:49 Bookmark this

Allergies 57

Allergies Drugs 57

Scienmag

JULY 5, 2022

Scientists have revealed the genetic and molecular structure of key molecules linked to the sometimes life-threatening mammalian-meat allergy brought on by tick bites. The […].

Allergies 79

Allergies Genetics Scientist Research 79

Medical Xpress

FEBRUARY 27, 2023

An electronic medical record (EMR) alert is effective for reducing food allergy panel ordering among pediatric and adult patients, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology, held from Feb. 24 to 27 in San Antonio.

Allergies 74

Allergies 74

Medical Xpress

APRIL 10, 2023

Spring allergies can be brutal, and many—but by no means all—sufferers reach for synthetic medications to combat their symptoms.

Allergies 75

Allergies Drugs 75

Trialfacts

MARCH 2, 2024

IRB: This study has been reviewed and approved by the Johns Hopkins Medical Center Institutional Review Board About the Study Did you know that nearly 3 percent of infants in the United States develop a food allergy within their first year of life? Let’s safely navigate the challenges of food allergies in the years to come!

Allergies 52

Allergies Research Development 52

Drug Discovery World

OCTOBER 13, 2022

New research has shown that standard cat allergy treatment can be enhanced to make it more effective and faster acting, and the benefits last for a year after treatment ends. The findings of the study, supported by the National Institutes of Health, were published in the Journal of Allergy and Clinical Immunology. .

Allergies 52

Allergies Gene Antibody Trials 52

Outsourcing Pharma

SEPTEMBER 16, 2021

The US agency has given the go-ahead to Cour Pharmaceuticals to evaluate the safety and efficacy of CNP-201, a drug intended to treat peanut allergies.

Allergies 105

Allergies FDA Approval Drugs Regulation 105